In summary, we have demonstrated that the combination of EGCG+tamoxifen significantly reduced ER-negative tumour growth and that this was driven primarily by an enhanced effect by the decreased protein expression of the EGFR, mTOR, and CYP1B1. The gene discussed is MTOR; the disease is neoplasm.